175 related articles for article (PubMed ID: 21205912)
1. Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.
Kelly-Cobbs AI; Harris AK; Elgebaly MM; Li W; Sachidanandam K; Portik-Dobos V; Johnson M; Ergul A
J Pharmacol Exp Ther; 2011 Apr; 337(1):9-15. PubMed ID: 21205912
[TBL] [Abstract][Full Text] [Related]
2. Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes.
Li W; Sachidanandam K; Ergul A
Neurol Res; 2011 Mar; 33(2):185-91. PubMed ID: 21801593
[TBL] [Abstract][Full Text] [Related]
3. Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes.
Abdelsaid M; Ma H; Coucha M; Ergul A
Life Sci; 2014 Nov; 118(2):263-7. PubMed ID: 24434796
[TBL] [Abstract][Full Text] [Related]
4. Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.
Sachidanandam K; Portik-Dobos V; Kelly-Cobbs AI; Ergul A
Can J Physiol Pharmacol; 2010 Jun; 88(6):616-21. PubMed ID: 20628426
[TBL] [Abstract][Full Text] [Related]
5. Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes.
Sachidanandam K; Portik-Dobos V; Harris AK; Hutchinson JR; Muller E; Johnson MH; Ergul A
Diabetes; 2007 Nov; 56(11):2753-8. PubMed ID: 17670915
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
[TBL] [Abstract][Full Text] [Related]
7. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.
Saleh MA; Pollock JS; Pollock DM
J Pharmacol Exp Ther; 2011 Jul; 338(1):263-70. PubMed ID: 21471190
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.
Sachidanandam K; Elgebaly MM; Harris AK; Hutchinson JR; Mezzetti EM; Portik-Dobos V; Ergul A
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2743-9. PubMed ID: 18424628
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1.
Harris AK; Hutchinson JR; Sachidanandam K; Johnson MH; Dorrance AM; Stepp DW; Fagan SC; Ergul A
Diabetes; 2005 Sep; 54(9):2638-44. PubMed ID: 16123352
[TBL] [Abstract][Full Text] [Related]
10. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.
Jarvis MF; Wessale JL; Zhu CZ; Lynch JJ; Dayton BD; Calzadilla SV; Padley RJ; Opgenorth TJ; Kowaluk EA
Eur J Pharmacol; 2000 Jan; 388(1):29-35. PubMed ID: 10657544
[TBL] [Abstract][Full Text] [Related]
11. Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control.
Abdelsaid M; Kaczmarek J; Coucha M; Ergul A
Life Sci; 2014 Nov; 118(2):268-73. PubMed ID: 24447630
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
[TBL] [Abstract][Full Text] [Related]
13. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.
Wanecek M; Oldner A; Sundin P; Alving K; Weitzberg E; Rudehill A
Eur J Pharmacol; 1999 Dec; 386(2-3):235-45. PubMed ID: 10618475
[TBL] [Abstract][Full Text] [Related]
14. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
Lee TM; Chen CC; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
[TBL] [Abstract][Full Text] [Related]
15. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
[TBL] [Abstract][Full Text] [Related]
16. Chronic endothelin antagonism restores cerebrovascular function in diabetes.
Dumont AS; Dumont RJ; McNeill JH; Kassell NF; Sutherland GR; Verma S
Neurosurgery; 2003 Mar; 52(3):653-60; discussion 659-60. PubMed ID: 12590691
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.
Sachidanandam K; Hutchinson JR; Elgebaly MM; Mezzetti EM; Dorrance AM; Motamed K; Ergul A
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R952-9. PubMed ID: 19176890
[TBL] [Abstract][Full Text] [Related]
18. Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation.
Kitada K; Yui N; Koyama M; Kimura K; Suzuki R; Tanaka R; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2011 Feb; 336(2):533-9. PubMed ID: 21075838
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes.
Elgebaly MM; Portik-Dobos V; Sachidanandam K; Rychly D; Malcom D; Johnson MH; Ergul A
Vascul Pharmacol; 2007; 47(2-3):125-30. PubMed ID: 17597010
[TBL] [Abstract][Full Text] [Related]
20. Diabetes-mediated middle cerebral artery remodeling is restored by linagliptin: Interaction with the vascular smooth muscle cell endothelin system.
Yasir A; Hardigan T; Ergul A
Life Sci; 2016 Aug; 159():76-82. PubMed ID: 26944436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
